Advertisement

Follow-Up Has Improved for AMI, Heart Failure Hospitalization

0

Disparities still persist in follow-up rates, with largest disparities seen between Black and White patients, Medicaid dual- versus non-dual-eligible

Potentially Hepatotoxic Botanicals Frequently Used in United States

0

At least one of the six botanical products was used by 15,584,599 U.S. adults, similar to number using simvastatin, NSAIDs

2021 to 2023 Saw Considerable Increase in Semaglutide Fills

0

Ozempic accounted for more than 70 percent of these fills, but increases were seen for all three drug brands

Prevalence of Overactive Bladder in U.S. Men Increased Significantly Since 2005

0

Increases in prevalence stronger for those aged 40 to 59 years, non-Hispanic White, non-Hispanic Black individuals, and those with overweight or obesity

Brand of Kratom Tied to One Death, Many Severe Illnesses, FDA Warns

0
By Ernie Mundell HealthDay Reporter MONDAY, Aug 5, 2024 (HealthDay News) -- Millions of Americans use the opioid-like herbal supplement known as kratom, but evidence...

Semaglutide Products Being Sold Online Without Prescriptions

0

Semaglutide was revealed in all samples purchased from online vendors, with considerably low purity levels

State-Level COVID-19 Restrictions Helped Save Lives

0

However, not all measures were equally effective, according to recent study

Smartphone-Based Acceptance and Commitment Therapy Aids Fibromyalgia

0

Significant improvement seen at 12 weeks compared with digital symptom tracking

Mpox Has Surged in Africa Amid Shortages of Vaccines and Treatments

0
By Robin Foster HealthDay Reporter FRIDAY, Aug. 2, 2024 (HealthDay News) -- Mpox cases have soared by 160% in Africa this year, as a lack...

Availability Increased With Approval of Naloxone as OTC Medication

0

Mean quoted out-of-pocket cost decreased pre- to post-OTC availability, with higher mean costs at independent pharmacies